Iron is essential for oxygen transport in the blood and cellular energy production, yet deficiencies are common in patients with chronic heart failure. This additionally impairs their physical capacity and quality of life. Iron deficiency is associated with hospitalization and early death, as highlighted in a review article published by the American College of Cardiology. Heart failure patients should therefore always have their iron status checked. Intravenous iron therapy appears to be most effective for treating iron deficiency in heart failure patients. It is also crucial for these patients to ensure adequate dietary iron intake while being mindful of factors that can limit iron absorption and utilization.

- but ageing processes and cholesterol-lowering drugs inhibit the body’s Q10 synthesis

No matter how you twist and turn it, cholesterol is an essential substance, and we humans produce most of it ourselves. What is important is to make sure that the cholesterol we have in our blood does not oxidize, and that is something which Q10 and other antioxidants take care of. Stable blood sugar levels also help us maintain a healthy cholesterol balance.

Cardiovascular diseases are widespread and one of the major causes of death. The risk is increased by factors such as ageing, diabetes, and overweight. One of the underlying causes is oxidative stress, which is an imbalance between free radicals and antioxidants. Q10, which is involved in cellular energy turnover, happens to be one of the most powerful antioxidants. According to a review article that is published in the scientific journal Antioxidants, supplementation with Q10 can reduce oxidative stress and cardiovascular mortality. It can also improve quality of life and increase the chances of survival. Generally speaking, Q10 has a huge potential for anyone with a desire to remain healthy, and it is important to choose a supplement with documented quality and bioavailability.

Many people suffer from chronic heart failure - often without knowing it. Numerous studies have shown that supplementing with Q10 can improve quality of life and even reduce mortality. An article published in Pharmacologic Therapy reviews the many Q10 studies and makes a point of saying that it is important to choose a Q10 preparation with good bioavailability.

Previous studies have shown that patients with heart disease have low levels of Q10 in the heart, and to a low amount of Q10 in the blood is associated with an increased risk of death from heart failure. However, it is only with the Q-symbio study that you can prove a significantly improved survival with Q10 in these patients with sufficiently high confidence.